The identified enriched KEGG pathways, including p53 signaling pathway, IL-17 signaling pathway, MAPK signaling pathway and NF-κB pathway, have been implicated in inflammation and tumor progression of CRC. The gene discussed is IL17A; the disease is neoplasm.